Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone in adolescents with schizophrenia
NCT00246285Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in schizophrenia, sponsored by Johnson & Johnson. Started Apr 2001; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00246285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246285.